Literature DB >> 10408365

Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance.

J S Navratil1, L C Korb, J M Ahearn.   

Abstract

Complete deficiency of C1q, the first component of the classical pathway of complement activation, is almost invariably associated with the development of systemic lupus erythematosus. Understanding why complement deficiency results in the specific autoimmune phenotype of SLE may provide valuable clues to the role of complement in the maintenance of immune tolerance. The following review will focus on the characteristics of complement-deficient SLE and the experimental evidence in support of our hypothesis that C1q may critically influence the immune response to self-antigen contained within surface blebs generated by apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408365     DOI: 10.1016/s0162-3109(99)00018-1

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  18 in total

Review 1.  Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement.

Authors:  S P Hart; J R Smith; I Dransfield
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

Review 2.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

Review 3.  Current topics in human SLE genetics.

Authors:  Maida Wong; Betty P Tsao
Journal:  Springer Semin Immunopathol       Date:  2006-08-29

Review 4.  Defects in the disposal of dying cells lead to autoimmunity.

Authors:  Udo S Gaipl; Sandra Franz; Reinhard E Voll; Ahmed Sheriff; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

5.  C1q complement component and -antibodies reflect SLE activity and kidney involvement.

Authors:  P Horák; Z Hermanová; J Zadrazil; H Ciferská; M Ordeltová; L Kusá; M Zurek; T Tichý
Journal:  Clin Rheumatol       Date:  2005-11-26       Impact factor: 2.980

Review 6.  Apoptosis and autoimmunity: complement deficiency and systemic lupus erythematosus revisited.

Authors:  J S Navratil; J M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

Review 7.  The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus.

Authors:  Bernadete L Liphaus; Maria Helena Bittencourt Kiss
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

Review 8.  Understanding systemic lupus erythematosus physiopathology in the light of primary immunodeficiencies.

Authors:  Magda Carneiro-Sampaio; Bernadete Lourdes Liphaus; Adriana Almeida Jesus; Clovis Artur A Silva; João Bosco Oliveira; Maria Helena Kiss
Journal:  J Clin Immunol       Date:  2008-04-11       Impact factor: 8.317

Review 9.  Current and Emerging Therapies for Lupus Nephritis.

Authors:  Samir V Parikh; Brad H Rovin
Journal:  J Am Soc Nephrol       Date:  2016-06-09       Impact factor: 10.121

Review 10.  [Pathogenesis of systemic lupus erythematosus].

Authors:  S Finzel; S Schaffer; M Rizzi; R E Voll
Journal:  Z Rheumatol       Date:  2018-11       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.